[Federal Register Volume 84, Number 154 (Friday, August 9, 2019)]
[Notices]
[Page 39323]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-17064]



[[Page 39323]]

=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the CDC/HRSA 
Advisory Committee on HIV, Viral Hepatitis and STD Prevention and 
Treatment (CHACHSPT)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
seeking nominations for membership on the CHACHSPT. The CHACHSPT 
consists of 18 experts in fields associated with public health; 
epidemiology; laboratory practice; immunology; infectious diseases; 
drug abuse; behavioral science; health education; healthcare delivery; 
state health programs; clinical care; preventive health; medical 
education; health services and clinical research; and healthcare 
financing, who are selected by the Secretary of the U.S. Department of 
Health and Human Services (HHS).

DATES: Nominations for membership on the CHACHSPT must be received no 
later than August 31, 2019. Packages received after this time will not 
be considered for the current membership cycle.

ADDRESSES: All nominations should be mailed to 1600 Clifton Road NE, 
Mailstop: E07, Atlanta, GA 30329-4027, emailed (recommended) to 
[email protected], or faxed to (404) 639-8317.

FOR FURTHER INFORMATION CONTACT: Margie Scott-Cseh, Committee 
Management Specialist, CDC, 1600 Clifton Road NE, Mailstop: E07, 
Atlanta, GA 30329-4027, (404) 639-8317, [email protected].

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV and 
STD Prevention and Treatment shall advise the Director, CDC, and the 
Administrator and Associate Administrator for HIV/AIDS, HRSA, regarding 
objectives, strategies, policies, and priorities for HIV and STD 
prevention and treatment efforts including surveillance of HIV 
infection, AIDS, STDs, and related behaviors; epidemiologic, 
behavioral, health services, and laboratory research on HIV/AIDS and 
STD; identification of policy issues related to HIV/STD professional 
education, patient healthcare delivery, and prevention services; agency 
policies about prevention of HIV/AIDS and other STDs, treatment, 
healthcare delivery, and research and training; strategic issues 
influencing the ability of CDC and HRSA to fulfill their missions of 
providing prevention and treatment services; programmatic efforts to 
prevent and treat HIV and STDs; and support to the agencies in their 
development of responses to emerging health needs related to HIV and 
other STDs.
    Nominations are being sought for individuals who have expertise and 
qualifications necessary to contribute to the accomplishments of the 
committee's objectives. Nominees will be selected based on expertise in 
the fields of HIV/AIDS, Viral Hepatitis and STD prevention, control and 
treatment. Experts in the disciplines of public health; epidemiology; 
laboratory practice; immunology; infectious diseases; drug abuse; 
behavioral science; health education; healthcare delivery; state health 
programs; clinical care; preventive health; medical education; health 
services and clinical research; and healthcare financing. Federal 
employees will not be considered for membership. Members may be invited 
to serve for up to four-year terms.
    Selection of members is based on candidates' qualifications to 
contribute to the accomplishment of CHACHSPT objectives. The U.S. 
Department of Health and Human Services policy stipulates that 
committee membership be balanced in terms of points of view 
represented, and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens, and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships. Committee 
members are Special Government Employees (SGEs), requiring the filing 
of financial disclosure reports at the beginning and annually during 
their terms. CDC reviews potential candidates for CHACHSPT membership 
each year, and provides a slate of nominees for consideration to the 
Secretary of HHS for final selection. HHS notifies selected candidates 
of their appointment near the start of the term in December 1, 2020, or 
as soon as the HHS selection process is completed. Note that the need 
for different expertise varies from year to year and a candidate who is 
not selected in one year may be reconsidered in a subsequent year. SGE 
Nominees must be U.S. citizens, and cannot be full-time employees of 
the U.S. Government. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address)
    [ssquf] At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.).
    Nominations may be submitted by the candidate him- or herself, or 
by the person/organization recommending the candidate. The Director, 
Strategic Business Initiatives Unit, Office of the Chief Operating 
Officer, Centers for Disease Control and Prevention, has been delegated 
the authority to sign Federal Register notices pertaining to 
announcements of meetings and other committee management activities, 
for both the Centers for Disease Control and Prevention and the Agency 
for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2019-17064 Filed 8-8-19; 8:45 am]
 BILLING CODE 4163-18-P